Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

IM Cannabis Corp. (C:IMCC)

Business Focus: N/A

Sep 13, 2021 08:43 am ET
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations
Sep 08, 2021 07:30 am ET
IMC Provides Further Details on Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / September 8, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, provides details of the shares issued as part of the share consideration paid in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading center IMC-GDP license from Panaxia Ph
Sep 03, 2021 08:35 am ET
Cannabis Executives Present: Cannabis Investor Conference September 8th & 9th
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
Sep 02, 2021 08:35 am ET
Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th
NEW YORK, Sept. 2, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 11:30 AM ET on Wednesday, September 8th.  
Aug 19, 2021 07:33 pm ET
The Flowr Corporation Provides Operational Update
The Flowr Corporation (“Flowr” or the “Company”) (TSXV: FLWR, OTC: FLWPF) is pleased to provide an operational update on its Canadian and European operations and a renewed focus to maintaining its status as a premium cannabis producer and making...
Aug 09, 2021 07:30 am ET
IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the signing of a binding letter of intent (the "Binding LOI") with cbdMD, Inc. (YCBD, YCBDpA), one of the leading and most highly trusted and recognized CBD
Aug 03, 2021 07:30 am ET
IMC Announces Results of its Annual General and Special Meeting of Shareholders
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 3, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the voting results from its annual general and special meeting of shareholders held on Wednesday July 28, 2021 (the "Meeting").
Jul 28, 2021 08:50 am ET
IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way
TORONTO, ON, GLIL YAM and NATANYA, ISRAEL / ACCESSWIRE / July 28, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the acquisition of the outstanding ordinary shares of R.A. Yarok Pharm Ltd. ("Pharm Yarok"), Rosen High Way Ltd. ("Rosen High Way"
Jul 23, 2021 08:40 am ET
IM Cannabis Provides Update on German Operations and Financial Outlook
TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces the completion of a new, state-of-the-art logistics centre in Germany (the "Logistics Centre") that will allow Adjupharm GmbH ("Adjupharm"), the Company's fully licensed EU-GMP subsidiary, to internally manage a
Jul 13, 2021 07:55 am ET
IM Cannabis Provides Business, Legal and Regulatory Update
TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to provide a business, legal and regulatory update on its operations in Germany and Israel.
Jul 09, 2021 08:45 am ET
IM Cannabis Closes Acquisition of MYM Nutraceuticals
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC)(CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, and MYM Nutraceuticals Inc. ("MYM"), a Canadian cultivator, processor, and distributor of premium cannabis, are pleased to announce, further to IMC's press release on July 6, 2021, the closing of IMC's acquisition of MYM Nutraceuticals Inc. ("MYM") (CSE:MYM), pre
Jul 06, 2021 07:25 am ET
MYM Shareholders Overwhelmingly Approve Plan of Arrangement with IM Cannabis
Highland Grow is currently profitable on an EBITDA basis, unlocks margin expansion and is expected to be immediately accretive to IM Cannabis
Jul 05, 2021 08:35 am ET
Cannabis Investor Conference Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations
Jun 28, 2021 07:30 am ET
IM Cannabis Proposed Acquisition of MYM Receives Positive Recommendations from Proxy Advisory Firms Glass Lewis and ISS
Glass Lewis and Institutional Shareholder Services recommend that MYM shareholders vote FOR Transaction with IMCC
Jun 23, 2021 08:35 am ET
Cannabis Industry Investor Conference: Company Executives Present June 29th & 30th
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
Jun 17, 2021 09:05 am ET
IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions
Conditions Evaluated Include Oncology, PTSD, Rheumatoid Arthritis, Chronic Pain, Insomnia, Back Pain and Inflammatory Bowel Diseases
Jun 07, 2021 07:50 am ET
IM Cannabis Announces Supply Agreement with Canadian LP The Flowr Corporation; Plan to Import Ultra-Premium Products as part of Enhanced Portfolio to Meet Growing Israeli Demand
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 7, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical") has signed a multi-year supply agreement with The Flowr Corporation ("Flowr") (TSX.V:FLWR, OTC:FLWPF), a Canadian licensed producer of ultra-premium adult-use recreational and medical cannabis
Jun 07, 2021 06:30 am ET
The Flowr Corporation Announces Export Agreement to Israel with Focus Medical Herbs and IM Cannabis
The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announce that it has entered into a supply agreement (“Supply Agreement”) with Focus Medical Herbs Ltd. (“Focus Medical”), a company which IM Cannabis Corp....
Jun 01, 2021 08:40 am ET
May 17, 2021 01:55 pm ET
IM Cannabis Reports Record Q1 2021 Results
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 17, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce its unaudited financial results for the first quarter ended March 31, 2021. All figures are expressed in Canadian dollars unless otherwise indicated.
May 10, 2021 08:00 am ET
IM Cannabis Announces Closing of US$ 35 Million Equity Financing
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 10, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE: IMCC), (NASDAQ: IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the closing of its previously announced overnight marketed offering (the "Offering") of 6,086,956 common shares of the Company (each an "Offered Share") at a price of US$5.75 per Offered Share for aggregate gross
May 05, 2021 09:20 am ET
IM Cannabis Announces Pricing of Proposed Public Offering of Securities
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 5, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that is has entered into a best-efforts agency agreement (the "Agency Agreement") in connection with its previously announced overnight marketed offering (the "Offering") of common shares of the Company (e
May 04, 2021 06:35 pm ET
IM Cannabis Announces Proposed Public Offering of Securities
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 4, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that it has commenced an overnight marketed offering (the "Offering") of the Company's common shares (each an "Offered Share") on a best-efforts agency basis. The Company may also issue to purchasers of Offered Shares, for no
Apr 30, 2021 12:20 pm ET
IM Cannabis Acquires Israel's Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand
With Israel's Fast-Paced E-Commerce Adoption and Cannabis Market's High Growth Rate (Averaging 4 Percent1 per Month), Panaxia's Online Platform to Support Patient Base Expansion
Apr 23, 2021 08:55 am ET
IM Cannabis Reports Fiscal 2020 Results; Provides Preliminary Q1 Results and Q2 Outlook
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / April 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce its financial results for the fourth quarter and financial year ended December 31, 2020.
Apr 22, 2021 08:35 am ET
420 Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations
Apr 19, 2021 08:30 am ET
MYM Continues to Secure Additional Support for Merger with IMCC
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company"), is pleased to announce that it has received additional voting support agreements in connection with the proposed merger with IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) ("IMCC") which was announced on April 1, 2021 (the "Transaction"). The total of voting support agreements for the Transaction has grown to 44.4% of all votes, or 162.7 million shares, an increase from 41.7% on April 1,, 2021. A total of 66 & 2/3rds of all common and exchangeable shares voted is required to approve the Transaction as well as a majority of the minority vote in accordance with Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions.
Apr 16, 2021 08:35 am ET
Cannabis Industry Investor Conference: Company Executives Present April 20th
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
Apr 13, 2021 07:50 am ET
Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market
TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Canada, Israel and Germany, announced that its subsidiary, Adjupharm GmbH ("Adjupharm"), recently signed a supply agreement (the "Supply Agreement") with MediPharm Labs Australia Pty Ltd, a subsidiary of MediPharm Labs Corp. ("MediPharm Labs") (TSX:LABS), (OTCQX:M
Apr 12, 2021 08:00 am ET
IM Cannabis Provides Update on Adjupharm Business Developments in Germany
TORONTO, ON, BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 12, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Canada, Israel and Germany, today provided a corporate update on its operations in Germany, including the expansion of its product portfolio following the signing of a new supply agreement.
Apr 01, 2021 11:51 am ET
IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow
Toronto, Ontario and Vancouver, British Columbia and Glil Yam, Israel--(Newsfile Corp. - April 1, 2021) - IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) (the "Company" or "IMC"), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada is pleased to announce that it has entered into a definitive agreement (the "Arrangement Agreement") to acquire MYM Nutraceuticals Inc. ("MYM") and its licensed producer subsidiary Highland Grow Inc. ("Highland Grow"), pursuant to a plan of arrangement to be completed under the Business Corporations Act (British Columbia) (the "Transaction"). The Transaction reinforces the Company's strategy as a leading global premium cannabis producer and purveyor. Following completion of the Transaction, expected to occur before the end of the second half of 2021, IMC will continue to operate under the IM Cannabis Corp. name with its common shares trading on the NASDAQ Capital Market and Canadian Securities Exchange under the ticker symbol "IMCC".
Apr 01, 2021 09:18 am ET
IIROC Trade Resumption - IMCC
VANCOUVER, BC, April 1, 2021 /CNW/ - Trading resumes in:
Apr 01, 2021 09:10 am ET
IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow
TORONTO, ON, VANCOUVER, BC, and GLIL YAM, ISRAEL / ACCESSWIRE / April 1, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada is pleased to announce that it has entered into a definitive agreement (the "Arrangement Agreement") to acquire MYM Nutraceuticals Inc. ("MYM") and its licensed producer subsidiary Highland Grow Inc. ("Highland Gro
Apr 01, 2021 09:06 am ET
IIROC Trading Halt - IMCC
VANCOUVER, BC, April 1, 2021 /CNW/ - The following issues have been halted by IIROC:
Mar 31, 2021 06:05 pm ET
IMC Announces Filing of Final Short Form Base Shelf Prospectus
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 31, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC)( NASDAQ:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel, Germany and Canada, is pleased to announce that it has filed a final short form base shelf prospectus (the "Shelf Prospectus") with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada and a corresponding shelf registrat
Mar 18, 2021 08:03 am ET
IMC Closes Acquisition of Trichome, Establishing Global Growth Platform in Both Adult Use and Medical Cannabis Markets
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 18, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the closing of its acquisition of Trichome Financial Corp. ("Trichome"), previously announced on December 30, 2020 (the "Transaction"). The Transaction was completed pursuant a plan of arrangement under the Business Corporations Act
Mar 12, 2021 08:10 pm ET
IMC Announces Filing of Preliminary Short Form Base Shelf Prospectus
TORONTO, ON & GLIL YAM, ISRAEL / ACCESSWIRE / March 12, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, has filed a preliminary short form base shelf prospectus (the "Shelf Prospectus") with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada, and will file a corresponding shelf registration statement on Form F-10 (the
Mar 08, 2021 08:00 am ET
IMC to Bring Canadian Premium Indoor High-THC Medical Cannabis to Israel with Imports from GTEC
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 8, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical"), with which IMC has exclusive agreements to distribute production under the IMC brand, has signed a multi-year supply agreement with GTEC Holdings Ltd. ("GTEC") (GTEC, GGTTF, 1BUP), a Canadian license
Mar 01, 2021 07:30 am ET
IM Cannabis Corp. Becomes First Israeli Medical Cannabis Operator to list on NASDAQ; Trading Today Under Symbol "IMCC"
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 1, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that the Company's common shares (the "Common Shares") will commence trading today on the NASDAQ Capital Market ("NASDAQ") under the ticker symbol "IMCC". IMC will be the first Israeli medical cannabis operator to list its shares on NASDAQ. The Company'
Feb 25, 2021 07:30 am ET
IM Cannabis Common Shares Expected to Begin Trading on NASDAQ on March 1, 2021
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / February 25, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that the Company's application to list its common shares on the NASDAQ Capital Market ("NASDAQ") has been approved. The Company's common shares (the "Common Shares") are expected to begin trading on NASDAQ under the ticker symbol "IMCC" on M
Feb 22, 2021 08:15 am ET
IMC Announces Additions to Board to Satisfy NASDAQ Director Independence Requirements
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / February 22, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that it has appointed Brian Schinderle and Haleli Barath to its board of directors (the "Board"). Both Mr. Schinderle and Ms. Barath are independent directors under applicable Canadian and United States securities laws.
Feb 16, 2021 08:00 am ET
IMC Common Shares Commences Trading on Consolidated Basis
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / February 16, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, today announced that further to its press releases dated December 17, 2020 and February 10, 2021, all of its issued and outstanding common shares ("Common Shares") began trading on a post-consolidation basis on February 12, 2021.
Feb 10, 2021 08:30 am ET
IMC Announces Details of Share Consolidation to Meet NASDAQ Capital Market Listing Requirement
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / February 10, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that, further to its press release dated December 17, 2020, it will be consolidating all of its issued and outstanding common shares ("Common Shares") on the basis of one (1) post-consolidation Common Share for each four (4) pre-consolidation Common Shares (t
Jan 26, 2021 08:00 am ET
IM Cannabis Receives DTC Eligibility as Part of NASDAQ Capital Market Listing Approval Process
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 26, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that the Company has received confirmation from The Depository Trust Company ("DTC") that its common shares ("Common Shares") are now eligible for electronic clearing and settlement through DTC in the United States. DTC eligibility is another
Jan 12, 2021 09:15 am ET
IM Cannabis Releases Message from CEO and 2021 Outlook
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 12, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to release a message from its Chief Executive Officer, Oren Shuster.
Dec 30, 2020 01:05 pm ET
IM Cannabis to Acquire Trichome in Landmark Transaction - Establishes Global Growth Platform and Leading Multi-Country Operator
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / December 30, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, and Trichome Financial Corp. ("Trichome") (CSE:TFC), are pleased to announce that they have entered into a definitive agreement (the "Arrangement Agreement") to combine their businesses into a global leader in adult-use recreational and medical cannabis (together, the "
Dec 30, 2020 12:17 pm ET
IIROC Trade Resumption - IMCC
VANCOUVER, BC, Dec. 30, 2020 /CNW/ - Trading resumes in:
Dec 30, 2020 08:16 am ET
IIROC Trading Halt - IMCC
VANCOUVER, BC, Dec. 30, 2020 /CNW/ - The following issues have been halted by IIROC:
Dec 17, 2020 08:00 am ET
IMC Announces Results of Special Meeting and NASDAQ Listing Application Milestone
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / December 17, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that shareholders approved all of the motions put forward at its special meeting of shareholders (the "Special Meeting") held yesterday, which included a motion authorizing a share consolidation (the "Share Consolidation") of the Compan
Nov 27, 2020 09:25 am ET
Nov 16, 2020 08:30 am ET
IMC Welcomes Israeli Government Action Towards Legalization of Recreational Cannabis
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 16, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that an Israeli government committee responsible for advancing cannabis market reform published a report concluding that it supports and recommends the legalization of adult-use recreational cannabis in the State of Israel (the "Report"). Based on the Report, the Israeli Ministry of Justice is exp
Oct 08, 2020 04:30 pm ET
IMC Applies to List its Common Shares on the NASDAQ Capital Market
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 8, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that it has applied to list its common shares (the "Common Shares") on the NASDAQ Capital Market ("NASDAQ") under the trading symbol "IMCC". The Common Shares of the Company will continue to be listed on the Canadian Securities Exchange under the same trading sym
Oct 07, 2020 08:30 am ET
Oct 06, 2020 08:30 am ET
Israeli Ministry of Health Opens International Export Market for Israeli Medical Cannabis Producers
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 6, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that the Israeli Ministry of Health has launched a new pilot program in which medical cannabis producers will be authorized to export medical cannabis, subject to making certain products available to patients in Israel at a fixed price of NIS14 per gram (CAD$5.50 per gram) and NIS10 (CAD$4.00 per gram) for pa
Sep 23, 2020 08:30 am ET
IM Cannabis Launches Sales of IMC-Branded Products in Germany, Adds to Pipeline of Purchase Agreements
IMC has now completed shipments of its branded flower products to four of the Company's ten distribution partners, marking IMC's official brand launch in Germany Three additional purchase commitments executed with German distributors IMC now has binding purchase commitments for 1,615kg of medical cannabis* Currency is in CAD$ unless specified otherwise
Sep 15, 2020 08:35 am ET
IM Cannabis Completes First Import into Germany, Further Strengthens Distribution Network
First shipment received into Germany from EU-GMP supply partner, allowing the Company to begin fulfilling purchase commitments for IMC-branded products Adjupharm adds Cansativa, Ilios and Farmako to its distribution network, platform now includes ten distributors* Currency is in CAD$ unless specified otherwise
Aug 26, 2020 03:40 pm ET
IM Cannabis Reports 62% Increase in Consolidated Revenue and 54% Gross Margin in Q2 2020
Consolidated revenue increased to $3.8 million in Q2 2020, from $2.3 million in the prior year, a 62% increase, and a 180% increase over Q1 2020 Gross margin before fair value impacts was 54% in Q2 2020 Q2 2020 milestones include: Six pharmacy sales agreements signed by Focus Medical to sell IMC-branded medical cannabis in Israel Execution of German distribution platform with seven binding sales commitments signed First imports from Spain and Canada into Israel by Focus Medical Gross proceeds of approximately $6.0 million from the exercise of warrants and broker compensation options* Currenc
Jul 27, 2020 08:30 am ET
IMC Announces Focus Medical Has Added Sixth Supplier Producing Under IMC Brand to Meet Growing Demand in Israel
Focus Medical has entered into a supply agreement with Israeli-based Ever Green for a potential term of up to ten years Focus Medical will purchase all medical cannabis produced by Ever Green from its 86,000 square foot facility in Moshav Sgula, Israel Supply is secured for the six previously announced binding sales agreements between Focus Medical and pharmacies in Israel, in which the Israeli pharmacies have agreed to purchase 33,075kg of IMC-branded medical cannabis over the next three years TORONTO and GLIL YAM, Israel, July 27, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (C
Jul 21, 2020 08:30 am ET
IMC Continues German Market Expansion with Purchase Commitments from Three Additional Distribution Partners
IMC continues execution of German strategy with seven distribution agreements signed, adding axicorp, canymed and Materia Now a total of 1,525kg of sales secured under binding purchase commitments in Germany in the next twelve months All products to be sold under the IMC brand* Currency is in CAD$ unless specified otherwise
Jul 15, 2020 08:00 am ET
IMC Bolsters German Sales Network with Purchase Commitment from Zur Rose Pharma GmbH
IMC delivering on German strategy with fourth binding purchase commitment with distribution partner in Germany Zur Rose Pharma GmbH is part of the Zur Rose Group – Europe's largest e-commerce pharmacy* Currency is in CAD$ unless specified otherwise
Jul 06, 2020 08:35 am ET
IMC Announces Business Update and Review of Q2 Milestones
IMC has bolstered the network of pharmacies, distributors and supply partners that are supporting the IMC brand in both Israel and Germany Decriminalization legislation in Israel to significantly increase market potential Formal launch of IMC brand in Germany expected in Q3 2020 Recent warrant exercise adds $6.0 million to treasury, IMC fully funded for existing growth initiatives* Currency is in CAD$ unless specified otherwise
Jun 30, 2020 08:30 am ET
IMC Reports Exercise of Warrants and Options
Adds $6.0 million to treasury, IMC fully funded for existing growth initiatives* Currency is in CAD$ unless specified otherwise
Jun 24, 2020 08:30 am ET
IMC Announces Efficacy of IMC Branded Strains in Reducing Migraines
Peer-reviewed study indicates two IMC branded medical cannabis strains were effective in reducing migraines in over 60% of treated patients Study conducted by Professor Dedi Meiri of Technion - Israeli Institute of Technology IMC continues to pursue evidence-based research for medical applications of cannabis TORONTO and GLIL YAM, Israel, June 24, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, announced today that a recent peer-reviewed study conducted by Professor Dedi
Jun 22, 2020 08:30 am ET
IMC Announces Israeli Government Advancing Cannabis Decriminalization
Decriminalization framework passes first reading with Ministerial Committee on Legislation IMC in market leading position in Israel to benefit from cannabis reforms and larger market TORONTO and GLIL YAM, Israel, June 22, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that the Israeli government has advanced legislation for the decriminalization of cannabis. Yesterday, June 21, the Ministerial Committee on Legislation approved a bill for the decr
Jun 18, 2020 08:30 am ET
IMC Announces Focus Medical's First Import from Canada to Israel, Strengthening International Network
Strong relationships with Canadian medical cannabis industry are a strategic imperative to IMC as a global medical cannabis brand Focus Medical has successfully imported approximately 200kg of medical cannabis from Canada, now seven suppliers cultivating under IMC brand across Israel, Spain and Canada IMC brand well positioned for Israeli government decriminalization reforms* Currency is in CAD$ unless specified otherwise
Jun 15, 2020 08:30 am ET
IMC Announces Binding Term Sheet for Distribution of CannEpil® in Israel
New generation of evidence-based cannabis products to be launched in Israel IMC to be exclusive distributor of CannEpil® in Israel for five-year term CannEpil® was developed by MGC Pharma for the treatment of refractory epilepsy* Currency is in CAD$ unless specified otherwise
Jun 10, 2020 08:30 am ET
IMC Supports Israeli Government Action Towards Cannabis Decriminalization
TORONTO and GLIL YAM, Israel, June 10, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to express its support for the Israeli government's plans to advance legislation on non-discrimination between medical and recreational cannabis users.
Jun 05, 2020 11:56 am ET
IM Cannabis Reports Q1/2020 Results and Strategic Milestones
Focus Medical has now entered into pharmacy sales agreements in Israel to deliver $193.5 million of medical cannabis over the next three years at an expected gross margin of 50% All supply for the pharmacy sales agreements has been secured, including initial shipments from Spain into Israel Momentum in revenue is expected to increase in Q2/2020 and gradually throughout the balance of the year* Currency is in CAD$ unless specified otherwise
Jun 04, 2020 08:30 am ET
IMC Announces Record Harvest by Focus Medical and Update on Israeli Operations
Focus Medical recently completed a semi-annual record harvest of over 3,000kg of medical cannabis Focus Medical's first two months of shipments of IMC-branded medical cannabis products to Super-Pharm and Panaxia totalled over 250kg Approximately 450kg of medical cannabis is expected for shipment in Q2 2020 under sales agreements with Super-pharm and Panaxia and 2,550kg of medical cannabis is expected for shipment in the latter half of 2020 under previously announced pharmacy sales agreements * Currency is in CAD$ unless specified otherwise
May 27, 2020 04:30 pm ET
IM Cannabis Announces Delay in Filing its Q1 2020 Financial Statements and MD&A
TORONTO and GLIL YAM, Israel, May 27, 2020  /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) announces that filing of the Company's interim financial statements for the three month period ended March 31, 2020 (the "Q1 Financial Statements") and associated management's discussion and analysis (the "Q1 MD&A", and collectively with the Q1 Financial Statements, the "Q1 Filings") will be postponed due to delays caused by the COVID-19 pandemic.
May 26, 2020 08:00 am ET
IMC Announces Focus Medical's Successful Import of Medical Cannabis from Spain to Israel
Focus Medical has successfully imported approximately 200kg of medical cannabis from Spain into Israel The medical cannabis was supplied by Linneo Health, the Company's strategic supply partner in Spain and an EU-GMP global supplier of medicinal cannabis Six suppliers now cultivating medical cannabis to Focus Medical for sale under the IMC brand in Israel* Currency is in CAD$ unless specified otherwise
May 19, 2020 08:12 am ET
IMC Approved for 4,000kg of Medical Cannabis Import to Germany
IMC's EU-GMP licensed subsidiary, Adjupharm, has been approved to import 4,000kg of medical cannabis into Germany from additional foreign suppliers pursuant to a license extension granted by BfArMThe License includes the ability to import flower and extracts from several countries, approved for both bulk and primary productsThe License allows all sales currently under binding commitment in Germany to be fulfilled from abroad TORONTO, GLIL YAM, Israel and BAD OLDESLOE, Germany, May 19, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical c
May 14, 2020 07:45 am ET
IMC Welcomes Approval of Medical Cannabis Exports by Israeli Government
Israeli Ministry of Economy signed a Free Export Order for medical cannabis productsGovernment to begin accepting medical cannabis export applications in 30 daysNew export order significantly increases international market potential for the IMC brand TORONTO and GLIL YAM, Israel, May 14, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that the Israeli Ministry of Economy signed a Free Export Order for medical cannabis products on May 13, 2020. In 3
May 12, 2020 08:16 am ET
IMC Signs Third Sales Agreement in Germany, Further Strengthening its Distribution Network
Executing on long-term strategy to build distribution platform across the large German marketSales commitment for 465kg of IMC-branded medical cannabis over the next twelve months Together with other announced binding purchase agreements in Germany, a total of 825kg of IMC-branded medical cannabis is committed for sale over the next twelve months *Currency is in CAD$ unless specified otherwise
May 07, 2020 08:00 am ET
IMC Expands into German Market through Execution of Two Binding Sales Commitments
First step in a long-term strategy to develop a network of distribution partners in order to maximize brand awareness among physicians, pharmacists and patients in Germany IMC's distribution subsidiary in Germany will deliver a total of 360kg of medical cannabis to two distributors in Germany beginning in June 2020 All medical cannabis sold to these distributors under the IMC brand * Currency is in CAD$ unless specified otherwise
Apr 27, 2020 08:30 am ET
IMC Announces New Supplier Signed by Focus Medical, Now Five Suppliers Cultivating for Focus Medical under IMC Brand
Focus Medical has entered into a supply agreement to purchase up to a total 8,060kg of medical cannabis between 2020 and 2023 Focus Medical has now secured all the supply required under the six binding pharmacy sales agreements it has signed In 2020, Focus Medical signed binding sales agreements for pharmacies to purchase 33,075kg in medical cannabis under the IMC brand, revenue of CAD$193.5 million to IMC over the next three years, at an expected gross margin of 50% TORONTO and GLIL YAM, Israel, April 27, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world
Apr 21, 2020 11:32 am ET
IIROC Trade Resumption - IMCC
VANCOUVER, April 21, 2020 /CNW/ - Trading resumes in:
Apr 21, 2020 10:21 am ET
IIROC Trading Halt - IMCC
VANCOUVER, April 21, 2020 /CNW/ - The following issues have been halted by IIROC:
Apr 20, 2020 04:30 pm ET
IM Cannabis Reports 72% Increase in Q4 2019 Consolidated Revenue
Consolidated revenues increased 72% to $2.5 million in Q4 2019, fiscal 2019 consolidated revenue increased 75% with a gross margin of 48% Strong financial position at December 31, 2019 with $13.9 million in cash, $21.7 million in working capital and no debt Sales agreements for $121.9 million in consolidated revenue to IMC over three years signed by Focus Medical subsequent to year-end*
Apr 16, 2020 08:30 am ET
IMC Announces Two Additional Binding Sales Agreements by Focus Medical - Adds CAD$14.5 Million in Revenue with Gross Margin of 50% Over Three-Year Period
Focus Medical has entered into two additional binding sales agreements: Max Pharm for up to 1,500kg over three years and Panaxia for 1,000kg of medical cannabis under the IMC brand Max Pharm adds IMC-branded products to its retail pharmacy and home delivery platform, and Panaxia will launch IMC products across the largest home delivery platform in Israel In 2020, Focus Medical has signed binding sales agreements to supply 20,475kg in medical cannabis under the IMC brand – totalling up to CAD$121.9 million in revenue to IMC over the next three years, at an expected gross margin of 50% TORON
Apr 13, 2020 10:44 am ET
IIROC Trade Resumption - IMCC
VANCOUVER, April 13, 2020 /CNW/ - Trading resumes in:
Apr 13, 2020 10:23 am ET
IMC Announces Three-Year CAD$80.4 Million Sales Agreement with Gross Margin of 50% by Focus Medical with Super Pharm, Israel's Largest Pharmacy Chain, for IMC-Branded Medical Cannabis Products
Focus Medical has entered into a three-year binding sales agreement with Super-Pharm, Israel's largest pharmacy chain, for 13,575kg of IMC branded medical cannabis productsSales to begin in April 2020 through Super-Pharm's omnichannel distribution network including 41 pharmacies licensed to sell medical cannabis, as well as home delivery and e-commerce platformsTo date in 2020, Focus Medical has signed binding sales agreements for 17,975kg of medical cannabis products with a value of CAD$107.4 million in revenue expected over the next three years TORONTO and GLIL YAM, ISRAEL, April 13, 202
Apr 13, 2020 07:58 am ET
IIROC Trading Halt - IMCC
VANCOUVER, April 13, 2020 /CNW/ - The following issues have been halted by IIROC:
Apr 08, 2020 08:00 am ET
IMC Announces Second Focus Medical Deal for Sales of Branded Products in Israeli Pharmacy Channel for 2,000kg
Focus Medical, entered into a two-year binding agreement to sell 1,000kg of medical cannabis a year to Shor Tabachnik pharmacies The two-year contract is valued at approximately CAD$12 million; now 4,400kg for an approximate value of CAD$27 million contracted over next three years All medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, Israel, April 8, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce
Apr 08, 2020 12:05 am ET
Isracann Closes JV Cannabis Farm Production Agreement With 3-Year Offtake in Israel
Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased...
Apr 02, 2020 08:00 am ET
IM Cannabis Provides Business Update on COVID-19
Israeli and German operations continue to advance strategic priorities, investments into innovation will be deferred Israeli operation to benefit from two supply agreements and one sales agreement recently signed by Focus Medical IM Cannabis currently has CAD$11.8 million in cash and no debt TORONTO and GLIL YAM, Israel, April 2, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to provide a business update to the investment community regarding the COVID-19 pand
Mar 31, 2020 08:00 am ET
IM Cannabis Adds New Partners for Supply of Medical Cannabis in Israel under IMC Brand
IMC continues to build asset-light business model to satisfy rising demand for medical cannabis in Israel with supply of approximately 2,600kg of medical cannabis per year using Focus Medical's proprietary genetics All medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, ISRAEL, March 31, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical"), a licensed medical
Mar 30, 2020 09:53 am ET
IM Cannabis to Expand IMC Brand in Pharmacies Across Israel
Focus Medical entered into a binding agreement to sell 800kg of medical cannabis a year to a group of pharmacies in Jerusalem over a period of three years Total contract value of approximately CAD$15 million All medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, ISRAEL, March 30, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical"), a licensed medical cannab
Mar 23, 2020 08:00 am ET
IM Cannabis Bolsters Supply of Medical Cannabis in Israel under IMC Brand due to Definitive Supply Agreement between Focus and Intelicanna
Intelicanna, an Israeli cannabis company traded on the Tel Aviv Stock Exchange under the ticker symbol "INTL", to supply a minimum of 500kg and up to 1,000kg of medical cannabis to Focus Medical using Focus Medical's proprietary geneticsAll medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, Israel, March 23, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medica
Mar 17, 2020 10:06 am ET
IM Cannabis Corp. Announces Annual General Meeting Results
TORONTO and GLIL YAM, Israel, March 17, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC) is pleased to announce that at the annual general meeting of shareholders of the Company (the "Meeting") held earlier today, the shareholders elected Oren Shuster, Marc Lustig, Steven Mintz, Rafael Gabay and Vivian Bercovici as directors of the Company. Incumbent director Jesse Kaplan did not seek re-election at the Meeting and Rafael Gabay and Vivian Bercovici were elected to the board of directors (the "Board") for the first time. The Board would like to thank Mr. Kaplan for his serv
Jan 30, 2020 12:05 pm ET
Israeli Government Approves First Export of Medical Cannabis from Israel to United Kingdom
TORONTO and GLIL YAM, Israel, Jan. 30, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is preparing for the expansion of medical cannabis export from Israel in light of the recent news about government approval and the completion of the first medical cannabis shipment from Israel to the United Kingdom.
Jan 28, 2020 06:00 am ET
IM Cannabis Continues European Expansion, Establishes Joint Venture and Supply Agreement in Greece
IMC to become 25% Joint Venture partner for cultivation and processing operation in Greece Preferred supply agreement to diversify sources of EU-GMP medical cannabis for export to Germany and other emerging markets TORONTO and GLIL YAM, Israel, Jan. 28, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that on January 23, 2020 it signed definitive agreements to establish a medical cannabis cultivation and processing joint venture in Greece (the "Jo
Jan 07, 2020 07:00 am ET
IM Cannabis Expands Innovation Portfolio with Investment in Xinteza to Develop Innovative Biosynthesis Technology based on Weizmann Institute Research
TORONTO and GLIL YAM, Israel, Jan. 7, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering and innovation focused medical cannabis companies with operations in Israel and across Europe, is pleased to announce that it has invested in a unique biosynthesis technology by entering into a share purchase agreement dated December 26, 2019 with Xinteza API Ltd. ("Xinteza") whereby the Company will acquire 25% of Xinteza's outstanding common shares for consideration of up to US$1.7 million. IMC's investment will be funded with existing cash resources.
Jan 06, 2020 07:00 am ET
IM Cannabis Releases Message from CEO and Recent Milestones
TORONTO and GLIL YAM, Israel, Jan. 6, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering and innovation focused medical cannabis companies with operations in Israel and across Europe, is pleased to release a message from its Chief Executive Officer, Oren Shuster.
Dec 18, 2019 08:15 am ET
IM Cannabis Corp. Provides Israeli Market Update
TORONTO and GLIL YAM, Israel, Dec. 18, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is providing an update on an interim order recently issued by the Israeli High Court of Justice (the "High Court") (the "Interim Order") requiring medical cannabis cultivators and production companies in Israel to extend the supply of medical cannabis to certain patients who, under the former regulatory regime, were licensed to receive medical cannabis until July 30, 2019, as per condi
Dec 06, 2019 06:00 am ET
IMCC Appoints Yaron Berger as CEO of IMC Holdings
Mr. Berger brings over 10 years of experience in managing large-scale operations in the government and private sectors including as the head of a leading telemedicine and pharmaceutical distribution company Mr. Berger established Greenpharma, one of Israel's first online pharmacies focused on medical cannabis patients Oren Shuster to remain CEO of IM Cannabis Corp. TORONTO and GLIL YAM, Israel, Dec. 6, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMCC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations across Europe, is pleased to announce the appoin
Dec 04, 2019 06:00 am ET
IM Cannabis to Host a Live Investor Webcast on December 10, 2019
IM Cannabis Corp. invites individual and institutional investors, as well as advisors and analysts, to attend a real-time, interactive presentation TORONTO and GLIL YAM, Israel, Dec. 4, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations across Europe,  is pleased to announce that Oren Shuster, Chief Executive Officer, will present live at Grit Capital's Webcast Series on December 10, 2019 at 11:00am ET/8:00am PT.
Nov 29, 2019 03:30 pm ET
IMC Holdings Increases Consolidated Revenues by 70% in Third Quarter of 2019
Consolidated revenues increased 70% to $2.3 million as sales volume and patient count continue to increase compared to previous year Focus increased its active registered patients by 28% to 4,636 as IMC-branded products maintain a leadership position in Israel Navasota completed private placement for gross proceeds of $20.4 million to fund the Company's Europe-focused growth strategy* Currency is in Canadian dollars unless specified otherwise.
Nov 21, 2019 03:30 pm ET
IM Cannabis Warrants Begin Trading on CSE
TORONTO and GLIL YAM, Israel, Nov. 21, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations across Europe, is pleased to announce that 9,730,258 warrants of the Company (the "Warrants") have begun trading on the Canadian Securities Exchange (the "CSE") under the trading symbol "IMCC.WT". Each Warrant, entitles the holder thereof to purchase one common share in the capital of the Company at an exercise price of $1.30 until October 11, 2021. 
Nov 18, 2019 06:00 am ET
IM Cannabis Corp. Applies for Listing of Warrants on the CSE
TORONTO and GLIL YAM, Israel, Nov. 18, 2019 /CNW/ - IM Cannabis Corp. (formerly Navasota Resources Inc.) (the "Company" or "IMC") (CSE: IMCC) has applied to list 9,730,258 warrants of the Company (the "Warrants") for trading on the Canadian Securities Exchange (the "CSE"). The Warrants had previously been issued pursuant to the terms of a private placement offering of subscription receipts by a wholly owned subsidiary of the Company that was partially brokered by a syndicate of agents led by Cormark Securities Inc. and comprised of Canaccord Genuity Corp., First Republic Capital Corp., Haywo
Nov 12, 2019 06:00 am ET
IM Cannabis to Present at PI Financial Conference in London
TORONTO and GLIL YAM, Israel, Nov. 12, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations across Europe,  is pleased to announce that it will be presenting at the PI Financial Cannabis Conference in London, England on November 18, 2019.
Nov 05, 2019 01:33 pm ET
Canadian Securities Exchange Attracts First Israeli Company Listings
IM Cannabis becomes third Israeli cannabis listing in past six weeks
Nov 05, 2019 06:00 am ET
IM Cannabis to Become First Israeli Medical Cannabis Operator to List on CSE and Provides Update on Operations in Europe and Israel
IMC is the first Israeli medical cannabis company to list its shares in Canada and will trade under the ticker "IMCC" on the Canadian Securities ExchangeThe Company recently completed a private placement for gross proceeds of over CAD$20 million to bolster its footprint across Europe, including Germany, Portugal and GreeceInitial shipment from the EU-GMP facility in Europe to Germany is expected in Q2 2020 TORONTO and GLIL YAM, Israel, Nov. 5, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC"), one of the world's pioneering medical cannabis companies with operations across Europe,  is